Myelodysplastic Myeloproliferative Neoplasms
📧 Sign up to get email alerts when something new happens for Myelodysplastic Myeloproliferative Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes [Phase 2]
This ClinicalTrials.gov entry reports a completed Phase 2 study evaluating amifostine in pediatric patients with newly diagnosed de novo mye…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment [Phase 2]
Phase 2 trial evaluating cyproheptadine and megestrol to prevent weight loss in children with cancer-related cachexia; the study has complet…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [NA]
This entry discusses donor stem cell transplantation as a treatment option for patients with hematologic cancers, metastatic kidney cancer, …
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
This Phase 2 trial evaluated donor stem cell transplantation for high-risk hematologic cancers. The study status is terminated and results w…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 3]
Phase 3 trial comparing intensive versus nonintensive chemotherapy in older adults with acute myeloid leukemia or myelodysplastic syndromes.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood and placental blood transplantation for hematologic cancers or aplastic anemia. The s…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial evaluating sirolimus, tacrolimus, thymoglobulin, and rituximab as graft-versus-host-disease prophylaxis in haploidentical and …
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease [NA]
A clinical trial update on early diagnostic methods for aspergillosis in patients at high risk due to treatment for hematologic cancers or o…
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update evaluating donor stem cell transplant for hematologic cancers, including leukemia and lymphoma, with results p…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia [Phase 2]
Phase 2 study of VNP40101M in acute myeloid leukemia and high-risk myelodysplastic syndromes has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: 3-AP and Cytarabine in Treating Patients With Hematologic Cancer [Phase 1]
The document reports the completion of a Phase 1 trial evaluating 3-AP with cytarabine in patients with leukemia and myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 trial evaluating VNP40101M in relapsed or refractory leukemia or myelodysplastic syndromes; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome [Phase 3]
A Phase 3 clinical trial evaluating chemotherapy in children with Down syndrome and myelodysplastic/myeloproliferative disorders, acute myel…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating the combination of thalidomide and epoetin alfa for treating anemia in patients with myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy [Phase 2]
Phase 2 trial update evaluating voriconazole to prevent fungal infections in children with neutropenia after chemotherapy. The study has com…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia [Phase 1]
Phase 1 trial evaluating radiolabeled monoclonal antibody therapy with etoposide followed by peripheral stem cell transplantation in patient…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Bevacizumab in Treating Patients With Myelodysplastic Syndrome [Phase 1, Phase 2]
Bevacizumab was studied in patients with myelodysplastic syndrome in Phase 1 and Phase 2 trials. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Studying Fentanyl in Patients With Cancer
A Johns Hopkins cancer center trial evaluating fentanyl in cancer patients has been terminated. The study encompassed multiple cancer-relate…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation after conditioning with busulfan, fludarabine, and antithymocyte globulin in patien…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow transplantation in advanced hematologic cancers. The tria…
-
CLINICAL_TRIALS research · 2013-02-20Clinical Trial Update: Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating infusion of donor-derived natural killer cells after donor stem cell transplant for various …
-
CLINICAL_TRIALS withdrawal · 2013-02-15Clinical Trial Update: Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies [Phase 1, Phase 2]
Clinical trial update notes the withdrawal of a Phase 1/2 study evaluating antimicrobial versus saline solutions to maintain catheter patenc…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders [Phase 1]
Phase 1 study assessing decitabine with FR901228 (romidepsin) in patients with relapsed or refractory leukemia, myelodysplastic syndromes, a…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating thalidomide for anemia in patients with myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update describing a conditioning regimen of melphalan, fludarabine, and alemtuzumab followed by peripheral stem cell …